Do new biologics meet the unmet medical need in rheumatoid arthritis? Safety and efficacy of abatacept following B-cell depletion

Rheumatology (Oxford). 2011 Jan;50(1):243-4. doi: 10.1093/rheumatology/keq258. Epub 2010 Aug 17.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Abatacept
  • Aged
  • Antirheumatic Agents / adverse effects*
  • Arthritis, Rheumatoid / drug therapy*
  • B-Lymphocytes / drug effects*
  • Biological Products / adverse effects*
  • Female
  • Humans
  • Immunoconjugates / adverse effects*
  • Male
  • Middle Aged
  • Switzerland

Substances

  • Antirheumatic Agents
  • Biological Products
  • Immunoconjugates
  • Abatacept